|
---|
Category:Safety Evaluation Report
MONTHYEARML23047A0252023-02-28028 February 2023 Shine Technologies, LLC - Safety Evaluation Report: Operating License Application for a Medical Radioisotope Production Facility ML22316A0542022-11-12012 November 2022 Safety Evaluation Report for Shine Technologies, LLC Operating License Application - Chapter 7 ML22316A0532022-11-12012 November 2022 Safety Evaluation Report for Shine Technologies, LLC Operating License Application - Chapter 12 ML22314A1442022-11-10010 November 2022 Safety Evaluation Report for Shine Technologies, LLC Operating License Application - Chapter 6 ML22314A2122022-11-10010 November 2022 Safety Evaluation Report for Shine Technologies, LLC Operating License Application - Appendix a, Phased Approach ML22314A1592022-11-10010 November 2022 Safety Evaluation Report for Shine Technologies, LLC Operating License Application - Chapters 16, 17 and 18 ML22314A1552022-11-10010 November 2022 Safety Evaluation Report for Shine Technologies, LLC Operating License Application - Chapter 14 ML22314A2712022-11-10010 November 2022 Safety Evaluation Report for Shine Technologies, LLC Operating License Application - Chapter 13 ML22314A1492022-11-10010 November 2022 Safety Evaluation Report for Shine Technologies, LLC Operating License Application - Chapter 9 ML22314A1362022-11-10010 November 2022 Safety Evaluation Report for Shine Technologies, LLC Operating License Application - Chapter 3 ML22314A1432022-11-10010 November 2022 Safety Evaluation Report for Shine Technologies, LLC Operating License Application - Chapter 5 ML22314A1532022-11-10010 November 2022 Safety Evaluation Report for Shine Technologies, LLC Operating License Application - Chapter 10 ML22314A1392022-11-10010 November 2022 Safety Evaluation Report for Shine Technologies, LLC Operating License Application - Chapter 4 ML22314A1542022-11-10010 November 2022 Safety Evaluation Report for Shine Technologies, LLC Operating License Application - Chapter 11 ML22314A1312022-11-10010 November 2022 Safety Evaluation Report for Shine Technologies, LLC Operating License Application - Chapter 1 ML22314A1582022-11-10010 November 2022 Safety Evaluation Report for Shine Technologies, LLC Operating License Application - Chapter 15 ML22314A1332022-11-10010 November 2022 Safety Evaluation Report for Shine Technologies, LLC, Operating License Application - Chapter 2 ML22314A1452022-11-10010 November 2022 Safety Evaluation Report for Shine Technologies, LLC Operating License Application - Chapter 8 ML22292A3092022-10-20020 October 2022 Shine OL SER, Appendix a, Phased Startup Approach Redacted ML22292A3102022-10-20020 October 2022 Shine OL SER Chapter 7.4.3 Pics ML22249A3262022-09-0606 September 2022 Shine OL SER, Chapter 14 - Technical Specifications ML22199A3032022-07-18018 July 2022 Shine OL SER Chapter 7 with No Open Items (Redacted) ML22193A2782022-07-12012 July 2022 Shine OL SER Chapter 3.4.1 with No Open Items - Design Criteria ML22193A2792022-07-12012 July 2022 Shine OL SER Chapter 12 with No Open Items - Conduct of Operations ML22193A2802022-07-12012 July 2022 Shine OL SER Chapter 12.11 with No Open Items ML22193A2812022-07-12012 July 2022 Shine OL SER Chapter 7.4.9 with No Open Items - Human Factors Engineering ML22193A2822022-07-12012 July 2022 Shine OL SER Chapter 9a.4.3 with No Open Items - Fire Protection Systems and Programs ML22136A3022022-05-16016 May 2022 Shine OL SER, Chapter 13, Accident Analysis (Redacted) ML22131A2732022-05-11011 May 2022 Shine OL SER Chapter 12.7 with No Open Items ML22131A2912022-05-11011 May 2022 Shine OL SER Chapter 6b.3 with No Open Items ML22131A2692022-05-11011 May 2022 Shine OL SER Chapter 12.13 with No Open Items ML22118A7622022-04-28028 April 2022 Shine OL SER Chapter 8 with No Open Items ML22118A7642022-04-28028 April 2022 Shine OL SER Chapter 9 with No Open Items ML22118A8622022-04-28028 April 2022 Shine OL SER Chapter 11 with No Open Items ML22118B1192022-04-28028 April 2022 Shine OL SER Chapter 3 with No Open Items ML22073A1982022-03-14014 March 2022 Shine OL SER Chapter 1 with No Open Items ML22073A2012022-03-14014 March 2022 Shine OL SER Chapter 2 with No Open Items ML22073A2032022-03-14014 March 2022 Shine OL SER Chapter 4 with No Open Items ML22073A2042022-03-14014 March 2022 Shine OL SER Chapter 5 with No Open Items ML22073A2082022-03-14014 March 2022 Shine OL SER Chapter 6 with No Open Items ML22073A2092022-03-14014 March 2022 Shine OL SER Chapter 12.9 with No Open Items ML15267A8182015-10-0808 October 2015 Shine SER Chapter 05 ML15267A8122015-10-0808 October 2015 Shine SER Chapter 12 ML15267A8202015-10-0808 October 2015 Shine SER Chapter 03 ML15267A8222015-10-0808 October 2015 Shine SER Chapter 02 ML15267A8242015-10-0808 October 2015 Shine SER Chapter 01 ML15267A8252015-10-0808 October 2015 Shine SER References ML15267A8262015-10-0808 October 2015 Shine SER Chapter 15 ML15267A8272015-10-0808 October 2015 Shine SER Chapter 14 ML15267A8172015-10-0808 October 2015 Shine SER Chapter 06 2023-02-28
[Table view] |
Text
EXPERIMENTAL FACILITIES The SHINE Medical Technologies, LLC (SHINE, the applicant) final safety analysis report (FSAR) chapter 10, Experimental Facilities, states that the SHINE facility does not contain experimental facilities as described in NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors, Format and Content, issued February 1996 and the Final Interim Staff Guidance Augmenting NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors:
Format and Content, for Licensing Radioisotope Production Facilities and Aqueous Homogeneous Reactors, dated October 17, 2012.
The U.S. Nuclear Regulatory Commission staff evaluated the descriptions and discussions of the SHINE facility in the FSAR and finds that the final design of the SHINE facility does not contain experimental facilities. Therefore, the staff concluded that an evaluation of the guidelines of NUREG-1537, Part 2, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors, Standard Review Plan and Acceptance Criteria, issued February 1996 and the Final Interim Staff Guidance Augmenting NUREG-1537, Part 2, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors:
Standard Review Plan and Acceptance Criteria, for Licensing Radioisotope Production Facilities and Aqueous Homogeneous Reactors, dated October 17, 2012, is not required.
10-1